Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
NYSEFinancialsAsset ManagementSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
3.87 → 3.57 EPS · FY ending Dec 31, 2027 · 2 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 2 to 2; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for APAM yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Invest in distribution capabilities and EMEA presence | It expands in credit and alternatives and invests in EMEA distribution. | Intact | Progress score falls below 50% or no expansion in EMEA distribution | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in a supplied disclosure. Management reported: “In early August, Artisan was notified that a long-standing sub-advisory client is diversifying our mandate from a single-manager to a multi-manager structure.” “Artisan will remain one of three managers under the new structure, but the change is expected to result in the rebalancing of approximately $6 billion from the Global Value strategy in September 2026.” |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
APAM is an asset manager with a valuation-led, earnings-quality thesis rather than a clear turnaround story. Its current thesis state is watch: fresh earnings improved the signal, but recent financial performance remains below its industry cohort.
The evidence describes APAM as cheap versus peers, with a small negative expectations gap, meaning expectations appear slightly below the model’s view. The priced-in assessment is justified and fragility is low, so the evidence does not point to unusually concentrated expectations.
The latest earnings event was positive, and the signal improved from mildly favorable to favorable. Recent revenue was lower in 2026-Q3 than in 2025-Q4, while the supplied evidence does not establish delivery on the stated platform expansion or distribution priorities. Near term, a guidance cut is a meaningful risk, and recent performance below peers remains worth watching.
The multi-year view depends on whether APAM can improve relative performance and execute on platform priorities that the supplied disclosures do not substantiate. A guidance cut or falling rates would weigh on the setup, while continued earnings strength and higher guidance from Financials bellwethers could support sector momentum.
Over the next 1 to 3 years, APAM presents a cheap-versus-peers thesis backed by robust earnings quality, but the recent relative performance and execution evidence remain mixed. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Expand platform in credit and alternatives | It expands in credit and alternatives and invests in EMEA distribution. | Intact | Progress score falls below 50% or no growth in credit/alternatives | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Maintain stable profit margins near current levels | Artisan Partners grows revenue about 3% a year with steady profit margins. | Broken | Profit margins decline significantly below recent levels | Operating margin: 35.13% FY2026-Q3; GAAP. Published target: Maintain profit margins near current levels. Target percentage unit is not explicit. Oct 29, 202635.127577 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Sustain revenue growth near 3% annually | A primary condition in Artisan Partners Asset Management, Inc.'s published investment case. The stated target is >=2.8% YoY. | Improving | YoY revenue growth falls below 2.8% next year | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in a supplied disclosure. Management reported: “In early August, Artisan was notified that a long-standing sub-advisory client is diversifying our mandate from a single-manager to a multi-manager structure.” “Artisan will remain one of three managers under the new structure, but the change is expected to result in the rebalancing of approximately $6 billion from the Global Value strategy in September 2026.” Delivery assessment Nov 4, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$4.01 → $3.57 · observed estimates
$1.29B → $1.22B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $4.01 | $1,290,633,000 | 4 / 2 |
| 2026-07-25 | $4.01 | $1,290,633,000 | 4 / 2 |
| 2026-07-26 | $4.01 | $1,290,633,000 | 4 / 2 |
| 2026-07-27 | $4.03 | $1,297,183,000 | 4 / 2 |
| 2026-07-28 | $4.03 | $1,297,183,000 | 4 / 2 |
| 2026-07-29 | $4.03 | $1,297,183,000 | 4 / 2 |
| 2026-07-30 | $4.03 | $1,297,183,000 | 4 / 2 |
| 2026-07-31 | $4.00 | $1,300,539,000 | 4 / 2 |
| 2026-08-01 | $4.00 | $1,300,539,000 | 4 / 2 |
| 2026-08-02 | $4.00 | $1,300,539,000 | 4 / 2 |
| 2026-08-03 | $4.00 | $1,300,539,000 | 4 / 2 |
| 2026-08-04 | $4.00 | $1,300,539,000 | 4 / 2 |
| 2026-08-05 | $4.00 | $1,300,539,000 | 4 / 2 |
| 2026-08-06 | $4.00 | $1,300,539,000 | 4 / 2 |
| 2026-08-07 | $4.00 | $1,300,539,000 | 2 / 1 |
| 2026-08-08 | $4.00 | $1,300,539,000 | 4 / 2 |
| 2026-08-09 | $4.00 | $1,300,539,000 | 4 / 2 |
| 2026-08-10 | $4.00 | $1,300,539,000 | 4 / 2 |
| 2026-08-11 | $4.00 | $1,300,539,000 | 4 / 2 |
| 2026-08-12 | $4.02 | $1,300,539,000 | 4 / 2 |
| 2026-08-13 | $4.02 | $1,300,539,000 | 4 / 2 |
| 2026-08-14 | $4.00 | $1,300,539,000 | 2 / 1 |
| 2026-08-15 | $4.00 | $1,300,539,000 | 2 / 1 |
| 2026-08-16 | $4.00 | $1,300,539,000 | 2 / 1 |
| 2026-08-17 | $4.00 | $1,300,539,000 | 2 / 1 |
| 2026-08-18 | $4.00 | $1,300,539,000 | 2 / 1 |
| 2026-08-19 | $4.00 | $1,300,539,000 | 2 / 1 |
| 2026-08-20 | $4.02 | $1,300,539,000 | 2 / 1 |
| 2026-08-21 | $4.02 | $1,300,539,000 | 2 / 1 |
| 2026-08-22 | $4.02 | $1,300,539,000 | 2 / 1 |
| 2026-08-23 | $4.02 | $1,300,539,000 | 2 / 1 |
| 2026-08-24 | $4.02 | $1,300,539,000 | 2 / 1 |
| 2026-08-25 | $4.02 | $1,300,539,000 | 2 / 1 |
| 2026-08-26 | $4.02 | $1,300,539,000 | 2 / 1 |
| 2026-08-27 | $4.02 | $1,300,539,000 | 2 / 1 |
| 2026-08-28 | $4.02 | $1,300,539,000 | 2 / 1 |
| 2026-08-29 | $4.02 | $1,300,539,000 | 2 / 1 |
| 2026-08-30 | $4.02 | $1,300,539,000 | 2 / 1 |
| 2026-08-31 | $4.02 | $1,300,539,000 | 2 / 1 |
| 2026-09-01 | $4.02 | $1,300,539,000 | 2 / 1 |
| 2026-09-02 | $4.02 | $1,300,539,000 | 2 / 1 |
| 2026-09-03 | $4.02 | $1,300,539,000 | 2 / 1 |
| 2026-09-04 | $4.02 | $1,300,539,000 | 2 / 1 |
| 2026-09-05 | $4.02 | $1,300,539,000 | 2 / 1 |
| 2026-09-06 | $4.02 | $1,300,539,000 | 2 / 1 |
| 2026-09-07 | $4.02 | $1,300,539,000 | 2 / 1 |
| 2026-09-08 | $4.02 | $1,300,539,000 | 2 / 1 |
| 2026-09-09 | $4.02 | $1,300,539,000 | 2 / 1 |
| 2026-09-10 | $3.97 | $1,300,539,000 | 2 / 1 |
| 2026-09-11 | $3.97 | $1,300,539,000 | 2 / 1 |
| 2026-09-12 | $3.97 | $1,300,539,000 | 2 / 1 |
| 2026-09-13 | $3.97 | $1,300,539,000 | 2 / 1 |
| 2026-09-14 | $3.97 | $1,300,539,000 | 2 / 1 |
| 2026-09-15 | $3.97 | $1,300,539,000 | 2 / 1 |
| 2026-09-16 | $3.97 | $1,300,539,000 | 2 / 1 |
| 2026-09-17 | $3.97 | $1,300,539,000 | 2 / 1 |
| 2026-09-18 | $3.97 | $1,300,539,000 | 2 / 1 |
| 2026-09-19 | $3.97 | $1,300,539,000 | 2 / 1 |
| 2026-09-20 | $3.97 | $1,300,539,000 | 2 / 1 |
| 2026-09-21 | $3.97 | $1,300,539,000 | 2 / 1 |
| 2026-09-22 | $3.97 | $1,300,539,000 | 2 / 1 |
| 2026-09-23 | $3.97 | $1,300,539,000 | 2 / 1 |
| 2026-09-24 | $3.97 | $1,300,539,000 | 2 / 1 |
| 2026-09-25 | $3.97 | $1,300,539,000 | 2 / 1 |
| 2026-09-26 | $3.97 | $1,300,539,000 | 2 / 1 |
| 2026-09-27 | $3.97 | $1,300,539,000 | 2 / 1 |
| 2026-09-28 | $3.97 | $1,300,539,000 | 2 / 1 |
| 2026-09-29 | $3.97 | $1,300,539,000 | 2 / 1 |
| 2026-09-30 | $3.97 | $1,300,539,000 | 2 / 1 |
| 2026-10-01 | $3.97 | $1,300,539,000 | 2 / 1 |
| 2026-10-02 | $3.97 | $1,300,539,000 | 2 / 1 |
| 2026-10-03 | $3.87 | $1,266,627,500 | 2 / 1 |
| 2026-10-04 | $3.87 | $1,266,627,500 | 2 / 1 |
| 2026-10-05 | $3.87 | $1,266,627,500 | 2 / 1 |
| 2026-10-06 | $3.87 | $1,266,627,500 | 2 / 1 |
| 2026-10-07 | $3.87 | $1,266,627,500 | 2 / 1 |
| 2026-10-08 | $3.87 | $1,266,627,500 | 2 / 1 |
| 2026-10-09 | $3.87 | $1,266,627,500 | 2 / 1 |
| 2026-10-10 | $3.87 | $1,266,627,500 | 2 / 1 |
| 2026-10-11 | $3.75 | $1,240,627,500 | 2 / 1 |
| 2026-10-12 | $3.75 | $1,240,627,500 | 2 / 1 |
| 2026-10-13 | $3.66 | $1,240,627,500 | 2 / 1 |
| 2026-10-14 | $3.66 | $1,240,627,500 | 2 / 1 |
| 2026-10-15 | $3.65 | $1,235,830,500 | 2 / 1 |
| 2026-10-16 | $3.65 | $1,235,830,500 | 2 / 1 |
| 2026-10-17 | $3.65 | $1,235,830,500 | 2 / 1 |
| 2026-10-18 | $3.65 | $1,235,830,500 | 2 / 1 |
| 2026-10-19 | $3.65 | $1,235,830,500 | 2 / 1 |
| 2026-10-20 | $3.65 | $1,235,830,500 | 2 / 1 |
| 2026-10-21 | $3.65 | $1,235,830,500 | 2 / 1 |
| 2026-10-22 | $3.65 | $1,235,830,500 | 2 / 1 |
| 2026-10-23 | $3.65 | $1,235,830,500 | 2 / 1 |
| 2026-10-24 | $3.65 | $1,235,830,500 | 2 / 1 |
| 2026-10-25 | $3.65 | $1,235,830,500 | 2 / 1 |
| 2026-10-26 | $3.65 | $1,235,830,500 | 2 / 1 |
| 2026-10-27 | $3.65 | $1,235,830,500 | 2 / 1 |
| 2026-10-28 | $3.65 | $1,235,830,500 | 2 / 1 |
| 2026-10-29 | $3.62 | $1,235,830,500 | 2 / 1 |
| 2026-10-30 | $3.54 | $1,218,780,500 | 2 / 1 |
| 2026-10-31 | $3.57 | $1,219,860,000 | 2 / 1 |
| 2026-11-01 | $3.57 | $1,219,860,000 | 2 / 1 |
| 2026-11-02 | $3.57 | $1,219,860,000 | 2 / 1 |
| 2026-11-03 | $3.57 | $1,219,860,000 | 2 / 1 |
| 2026-11-04 | $3.57 | $1,219,860,000 | 2 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 1 Buy / Strong Buy · 2 Hold · 1 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 4 recorded
0 raises · 1 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.